N

Natera

Makes genetic tests for clinical care

Associate Director / Director of Product Management - Signatera Hematologic Oncology, Heme

Product ManagementConfirmed live in the last 24 hours
Full-timeRemote in USA$180.3k - $230.9k

About the Job

Requirements

  • A bachelor's degree in life sciences, statistics, engineering, or a related field is required; an advanced degree such as an MS, PhD, or MBA is preferred.
  • At least five years of experience in product management, product marketing, or market analytics at a diagnostics, biotech, or pharmaceutical company is required; seven or more years are preferred.
  • Hematologic oncology experience, especially in multiple myeloma and lymphoma, is strongly preferred.
  • Working knowledge of oncology molecular testing, next-generation sequencing, and biomarkers is required, including next-generation sequencing bioinformatics workflows such as variant calling, filtering, and interpretation, and genomic data analysis. MRD experience is preferred.
  • Experience with data analysis is required; SQL, Snowflake, or similar tools are preferred.
  • Familiarity with a high-complexity molecular laboratory, including cell-free DNA or plasma workflows, is a plus.
  • In-depth knowledge of whole genome sequencing and variant types, including structural variants, single nucleotide variants, and phased variants, is preferred.
  • Clinical-trial experience is required, including experience in investigational-use-only and in-vitro-diagnostic regulated environments.
  • Experience bringing a molecular test to market as a laboratory-developed test, including clinical validation and laboratory requirements, is required.
  • Experience designing or supporting clinical evidence generation, such as clinical validation studies, retrospective studies, or prospective trials, is required.
  • Prior key opinion leader engagement and external customer-facing experience are preferred.
  • The role requires availability during Pacific time hours and travel of 30–40% for advisory boards, congresses, and customer meetings.
  • The candidate must understand MRD in multiple myeloma and lymphomas, including how blood-based MRD testing fits with current bone marrow and imaging-based MRD assessment paradigms.
  • The candidate must understand how somatic variants are detected in whole genome sequencing and how they support MRD tracking in hematologic tumors.
  • The candidate must understand laboratory-developed-test market-entry requirements and the evidence needed for clinical adoption and payer coverage.
  • The candidate must be able to translate customer and clinical needs into clear product requirements.
  • The candidate must be able to build metrics, interpret data, and present findings, and must have basic financial modeling skills.
  • The candidate must be proficient with Microsoft Excel, Word, and PowerPoint.
  • The candidate must be able to lead without authority and influence cross-functional teams, explain complex topics simply, build relationships with thought leaders, manage several projects and tight deadlines, and balance fast development with quality standards.
  • The candidate must communicate clearly in writing and verbally, including with senior leadership, and function effectively in a highly matrixed cross-functional environment.

Responsibilities

  • Develop and execute the Signatera product roadmap for hematologic malignancies, beginning with multiple myeloma and lymphomas and extending to additional hematologic indications.
  • Lead market-entry planning for Signatera in hematology as a laboratory-developed test, including clinical validation requirements, CLIA and state requirements, market access, reimbursement and payer considerations, and launch readiness with Lab Operations, Regulatory, Medical, commercial teams, and Marketing.
  • Define product requirements for blood-based malignancies with R&D, Lab Operations, and Software Engineering, including assay, sample type, workflow, and reporting needs.
  • Lead product support for clinical trials using Signatera in hematology, including investigational-use-only use in studies with pharmaceutical and academic partners and the path toward in-vitro-diagnostic and regulated use.
  • Partner with Regulatory, Clinical, and Business Development on trial start-up, study requirements, and pharmaceutical and companion diagnostic opportunities.
  • Build product performance metrics and dashboards; analyze test volume, adoption, ordering patterns, turnaround time, and retention; and use results to prioritize improvements.
  • Partner with Medical Affairs and Clinical on evidence-generation strategy and execution, including identifying clinical gaps, designing studies, working with investigators and trial partners, and planning publications and congress presentations.
  • Guide product development for Signatera Genome in hematology, including whole genome sequencing technology, phased variants, and structural variants; work with R&D and Bioinformatics to define how these features improve tumor tracking and MRD sensitivity in hematologic malignancies.
  • Conduct voice-of-customer interviews, market research, and competitive and market intelligence in hematologic oncology.
  • Engage with key opinion leaders, advisory boards, and congresses, including ASH, EHA, and ASCO, and gather insights to guide product decisions.
  • Work with Marketing on product positioning, launch plans, pricing, and key collateral.
  • Build business cases and financial models to support product initiatives.
  • Present strategy, progress, and data-driven recommendations to executive leadership.
  • Perform other duties as assigned.

Desired Qualifications

  • An advanced degree (MS, PhD, or MBA) is preferred.
  • Seven or more years of product management, product marketing, or market analytics experience is preferred.
  • Hematologic oncology experience, especially in multiple myeloma and lymphoma, is strongly preferred.
  • MRD experience is preferred.
  • SQL, Snowflake, or similar data-analysis tools are preferred.
  • In-depth knowledge of whole genome sequencing and variant types, including structural variants, single nucleotide variants, and phased variants, is preferred.
  • Prior key opinion leader engagement and external customer-facing experience are preferred.
  • Site-based presence in San Carlos, California, Boulder, Colorado, or Austin, Texas is preferred.

About the Company

Natera

Makes genetic tests for clinical care

Natera develops genetic tests for clinicians caring for people with cancer, inherited conditions, pregnancies, and organ transplants, using DNA analysis to inform medical decisions. Its portfolio includes Signatera for tracking residual cancer, Panorama for prenatal screening, and Prospera for assessing transplanted organ health. The company combines laboratory analysis with software that distinguishes DNA fragments in blood, and earns revenue mainly from diagnostic testing, alongside licensing and services for research partners. Clinicians use its portals to order tests, track samples, and review results, while patients have access to genetic information sessions. Natera was founded in 2004 and is headquartered in Austin, Texas.

Company size
5,001-10,000
Company stage
IPO
Headquarters
Austin, TX
Founded
2004

Recently Posted Jobs

Explore more opportunities at Natera

See more jobs